Language selection

Search

Details for: RETEVMO

Company: LOXO ONCOLOGY INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02516918RETEVMOSELPERCATINIB40 MGCAPSULEORAL
02516926RETEVMOSELPERCATINIB80 MGCAPSULEORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Basis of Decision

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: